Tolvaptan treatment in an adult Fontan patient with protein-losing enteropathy: a serial 23Na-MRI investigation.
Julia MoosmannOkan TokaPeter LinzAnke DahlmannArmin M NagelMario SchifferMichael UderRobert CesnjevarSven DittrichChristoph KoppPublished in: Therapeutic advances in chronic disease (2021)
TLV in addition to loop diuretics improved clinical symptoms of PLE and lowered tissue sodium overload. Long-term effects should be further evaluated in Fontan patients.
Keyphrases
- end stage renal disease
- chronic kidney disease
- ejection fraction
- newly diagnosed
- magnetic resonance imaging
- peritoneal dialysis
- prognostic factors
- contrast enhanced
- case report
- transcription factor
- magnetic resonance
- protein protein
- small molecule
- depressive symptoms
- combination therapy
- binding protein
- sleep quality
- patient reported